Molecular Partners AG Sponsored ADR

MOLN

Healthcare Biotechnology

Molecular Partners AG Sponsored ADR’s revenue for fiscal 2024 (year ended December 2024) was $5.6 million, down 28.0% from fiscal 2023.

Revenue
−98.9%
EPS
+8.27%
Free cash flow
+11.1%

Quarter to September 2026, against a year earlier

3.22 0.03 −0.92%
Market cap
$119.2M
P/E
n/m
Fwd P/E
n/m
Dividend yield
—
F-score
2/9
ROIC
0.00%
Net debt / EBITDA
1.7×
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Total current assets
116.93 175.25 214.38 266.95 179.64 189.65 103.01 156.45 145.43 178.00
Total non-current assets
6.31 4.82 6.56 7.87 9.27 10.38 — — — —
Total Assets
123.24 180.07 220.94 274.82 188.92 200.04 108.18 158.32 — 180.49
Total current liabilities
13.31 12.25 16.06 18.08 51.28 61.51 29.49 37.62 14.43 15.46
Total non-current liabilities
12.97 6.94 8.36 10.31 20.26 24.16 — — — —
Total liabilities
26.28 19.19 24.42 28.39 71.53 85.68 52.37 64.75 28.26 47.36
Common Equity (Total)
96.96 160.89 196.52 246.43 117.38 114.36 55.81 93.58 119.11 133.13
Shareholders Equity (Total)
96.96 160.89 196.52 246.43 117.38 114.36 55.81 93.58 119.11 133.13
Total Debt
— — — 5.27 6.64 8.20 2.62 — — —

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 2 Nov 2026